FHFahimul Huda

Fahimul Huda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fahimul Huda has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ABIM Pilot Pathway E in Context: A Competency-Based Certification Model for International Medical Graduates

    by Fahimul Huda, Fatemeh Dehghani Firouzabadi, Meisam Hoseinyazdi, Zara Ali

    The American Board of Internal Medicine (ABIM) Pilot Pathway E introduces a competency-based certification model designed for international medical graduates (IMGs) who have completed prior internal medicine training outside the USA. Amid persistent physician workforce shortages and growing reliance on IMGs within internal medicine, innovative certification pathways are increasingly necessary. National Match data demonstrate both the substantial contribution of IMGs to internal medicine and the large pool of highly trained physicians navigating prolonged or duplicative training routes. Pilot Pathway E allows eligible IMGs, those who have completed at least 3 years of internal medicine training abroad and an ACGME-accredited ABIM subspecialty fellowship, to pursue eligibility for the Internal Medicine Certification Examination without repeating full US residency training. Competency is validated through accredited fellowship oversight and standardized clinical competence evaluations prior to examination approval. ABIM Pilot Pathway E establishes a 5-year pilot program integrating prior international internal medicine training with performance in US ACGME-accredited subspecialty fellowships. Drawing on lessons from alternative certification models in other specialties, this pathway reflects a broader shift from time-based requirements toward outcomes-based assessment. While implementation considerations include licensure, visa policy, and longitudinal outcome monitoring, Pathway E represents a structured effort to align global physician training with US certification standards while preserving rigor, safety, and educational quality.

  • Diagnostic Performance of Artificial Intelligence in Detecting and Distinguishing Pancreatic Ductal Adenocarcinoma via Computed Tomography: A Systematic Review and Meta-Analysis

    by Hamid Harandi, Mahdi Gouravani, Sogol Alikarami, Mohammad Shahrabi Farahani, Mohammad Ghavam, Soheil Mohammadi, Mohammad Amin Salehi, Sean Reynolds, Fatemeh Dehghani Firouzabadi, Fahimul Huda

    We conducted a systematic review and meta-analysis in diagnostic performance of studies that tried to use artificial intelligence (AI) algorithms in detecting pancreatic ductal adenocarcinoma (PDAC) and distinguishing them from other types of pancreatic lesions. We systematically searched for studies on pancreatic lesions and AI from January 2014 to May 2024. Data were extracted and a meta-analysis was performed using contingency tables and a random-effects model to calculate pooled sensitivity and specificity. Quality assessment was done using modified TRIPOD and PROBAST tools. We included 26 studies in this systematic review, with 22 studies chosen for meta-analysis. The evaluation of AI algorithms’ performance in internal validation exhibited a pooled sensitivity of 93% (95% confidence interval [CI], 90 to 95) and specificity of 95% (95% CI, 92 to 97). Additionally, externally validated AI algorithms demonstrated a combined sensitivity of 89% (95% CI, 85 to 92) and specificity of 91% (95% CI, 85 to 95). Subgroup analysis indicated that diagnostic performance differed by comparator group, image contrast, segmentation technique, and algorithm type, with contrast-enhanced imaging and specific AI models (e.g., random forest for sensitivity and CNN for specificity) demonstrating superior accuracy. Although the potential biases should be further addressed, results of this systematic review and meta-analysis showed that AI models have the potential to be incorporated in clinical settings for the detection of smaller tumors and underpinning early signs of PDAC.


  • Open Access

    Comparison of CT and Dixon MR Abdominal Adipose Tissue Quantification Using a Unified Computer-Assisted Software Framework

    by Li-Yueh Hsu, Zara Ali, Hadi Bagheri, Fahimul Huda, Bernadette A. Redd, Elizabeth C. Jones

    Purpose: Reliable and objective measures of abdominal fat distribution across imaging modalities are essential for various clinical and research scenarios, such as assessing cardiometabolic disease risk due to obesity. We aimed to compare quantitative measures of subcutaneous (SAT) and visceral (VAT) adipose tissues in the abdomen between computed tomography (CT) and Dixon-based magnetic resonance (MR) images using a unified computer-assisted software framework. Materials and Methods: This study included 21 subjects who underwent abdominal CT and Dixon MR imaging on the same day. For each subject, two matched axial CT and fat-only MR images at the L2-L3 and the L4-L5 intervertebral levels were selected for fat quantification. For each image, an outer and an inner abdominal wall regions as well as SAT and VAT pixel masks were automatically generated by our software. The computer-generated results were then inspected and corrected by an expert reader. Results: There were excellent agreements for both abdominal wall segmentation and adipose tissue quantification between matched CT and MR images. Pearson coefficients were 0.97 for both outer and inner region segmentation, 0.99 for SAT, and 0.97 for VAT quantification. Bland–Altman analyses indicated minimum biases in all comparisons. Conclusion: We showed that abdominal adipose tissue can be reliably quantified from both CT and Dixon MR images using a unified computer-assisted software framework. This flexible framework has a simple-to-use workflow to measure SAT and VAT from both modalities to support various clinical research applications.


  • The role of arachnoid granulations in idiopathic intracranial hypertension

    by Fahimul Huda, Ahmed Abdelmonem, Fatemeh Dehghani Firouzabadi, Venkata Naga Srinivas Dola, Ali Sheikhy, M Reza Taheri

    Objectives: Idiopathic intracranial hypertension (IIH) is a disease defined by elevated intracranial pressure (ICP) without an established etiology. Arachnoid granulations (AG) are conduits for CSF resorption from the subarachnoid space to the venous system. AG have been implicated to play a central role in maintaining CSF homeostasis. We tested the hypothesis that patients with fewer visible AG on MRI are more likely to present with IIH. Methods: In this institutional review board (Institutional Review Board)-approved retrospective chart review study, 65 patients with a clinical diagnosis of idiopathic intracranial hypertension were compared to 144 control patients who met inclusion/exclusion criteria. Patients’ signs and symptoms pertaining to IIH were obtained through the electronic medical record Brain MR images were reviewed for the number and distribution of AGs indenting the dural venous sinuses. The presence of imaging and clinical findings associated with long standing increased ICP was noted. Propensity score method (with inverse probability weighting technique) was used to compare case and control groups. Results: In the control group, the number of AG indenting the dural venous sinuses on MRI (NAG) was lower in women compared to men when matched for age (20–45 yo) and BMI (>30 kg/m2). The NAG was lower in 20–45 yo females in the IIH group as compared to the 20–45 yo females in the control group. This statistically significant difference persists when controlled for BMI. In contrast, the NAG in >45 yo females in the IIH group trended higher compared to the >45 yo females in the control group. Conclusion: Our results suggest that alterations in arachnoid granulations could play a role in the development of IIH.


  • Quantitative Ultrasound Assessment of Hepatic Steatosis

    by Artem Kaliaev, Wilson Chavez, Jorge Soto, Fahimul Huda, Hua Xie, Man Nguyen, Vijay Shamdasani, Stephan Anderson


  • Small subdural hemorrhages: Does size of intracranial hemorrhage impact symptoms after discharge?

    by Kyle Costenbader, Fahimul Huda, Muhammed Shand, Derek Brown, Marilyn Kraus, Reza Taheri


  • Acute cholecystitis: diagnostic value of dual-energy CT-derived iodine map and low-keV virtual monoenergetic images

    by Fahimul Huda, Christina A. LeBedis, Muhammad M. Qureshi, Stephan W. Anderson, Avneesh Gupta

    Purpose To compare conventional and dual-energy CT (DECT) for the diagnosis of acute cholecystitis and gangrene. Methods Fifty-seven consecutive adult patients with abdominal pain who underwent IV contrast-enhanced abdominal DECT on a dual-layer (dlDECT) or rapid-switching (rsDECT) scanner from September, 2018 to April, 2021 with cholecystectomy and pathology-confirmed cholecystitis were retrospectively reviewed, and compared with 57 consecutive adult patients without cholecystitis from the same interval scanned with DECT. Images were reviewed independently by two abdominal radiologists with 12 and 16 years of experience in two sessions 4 weeks apart, blinded to clinical data. Initially, only blended reconstructions (simulating conventional single-energy CT images) were reviewed (CT). Subsequently, CT and DECT reconstructions including low-keV virtual monoenergetic images and iodine maps were reviewed. Gallbladder fossa hyperemia, pericholecystic fluid, subjective presence of gangrene, heterogeneous wall enhancement, sloughed membranes, intramural air, abscess, overall impression of the presence of acute cholecystitis, and intramural iodine density were assessed. Results Gallbladder fossa hyperemia was detected with increased sensitivity on DECT (R1, 61.4%; R2, 75.4%) vs. CT (R1, 22.8%; R2, 15.8%). DECT showed increased sensitivity for gangrene (R1, 24.6%; R2, 38.6%) vs. CT (R1, 5.3%; R2, 14%), heterogeneous wall enhancement (DECT: R1, 33.3%; R2, 63.2% vs. CT: R1, 7%; R2, 31.6%), and cholecystitis (DECT: R1, 86%; R2, 89.5% vs. CT: R1, 77.2%; R2, 70.2%). In addition, DECT was more sensitive for the detection of acute cholecystitis (R1, 86%; R2, 89.5%) vs. CT (R1, 77.2%; R2, 70.2%). Iodine density threshold of 1.2 mg/ml, 0.8 mg/mL, and 0.5 mg/mL showed specificity for gangrenous cholecystitis of 78.26%, 86.96%, and 95.65%, respectively, using the rsDECT platform. Conclusion DECT showed improved sensitivity compared to conventional CT for detection of acute cholecystitis. Iodine density measurements may be helpful to diagnose gangrene.


  • Lumbar arachnoiditis: Does imaging associate with clinical features?

    by Vincent Parenti, Fahimul Huda, Perry K. Richardson, Derek Brown, Manek Aulakh, M. Reza Taheri